NYU Langone Health surgeons perform world s first total eye transplant with help from DePuy Synthes 3D surgical planning tools and patient-specific cutting gui
The proof-of-concept trial, dubbed IRIS-RA, is the first to investigate a treatment for rheumatoid arthritis that blocks a protein called neonatal Fc receptor (FcRn).
The antibody drug nipocalimab, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, has shown early promise for treating rheumatoid arthritis (RA) in a phase 2a trial.
Last week, J&J said the U.S. Department of Justice (DoJ), in July, requested documents and information related to its free and discounted eye surgery products
DePuy Spine, part of Johnson & Johnson s DePuy Synthes, is eliminating positions permanently at its Monument, Colo., facility, according to an Oct. 30 WARN letter.